en

PRODUCT DETAIL

Irinotecan Kabi 20 mg/ ml infúzny koncentrát

Code 59484
MA number 44/0472/08-S
Product Form: con inf 1x5 ml/100 mg (liek.inj.skl.hnedá)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Mutual recognition procedure
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
L01CE Topoisomerase 1 inhibitors
L01CE02 Irinotecan
Shelf life: 24
Container: brown glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 16.12.2008
SPC: SPC_Irinotecan Kabi 20 mg_ml infúzny koncentrát_04.2022.pdf  
PIL: PIL_Irinotecan Kabi 20 mg_ml infúzny koncentrát_04.2022.pdf  
Safety feature Yes
Data update: 19.04.2022
eu-flag.png sk-flag.png